<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34616013</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5438</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of human genetics : EJHG</Title><ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>SOD1 D91A variant in the southernmost tip of Europe: a heterozygous ALS patient resident on the island of Gozo.</ArticleTitle><Pagination><StartPage>856</StartPage><EndPage>859</EndPage><MedlinePgn>856-859</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-021-00975-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is frequently caused by mutations in the SOD1 gene. Here, we report the first SOD1 variant in Malta, an archipelago of three inhabited islands in southern Europe. We describe a patient with a sporadic form of ALS living on the island of Gozo in which the heterozygous SOD1 c.272A&gt;C; p.(Asp91Ala) variant was detected. The patient had a late onset (79 years), sensory impairments and rapid disease progression culminating in respiratory failure. ALS has not yet developed in any of the three additional family members in which the D91A variant was identified. None of the healthy controls from the Maltese population were found to carry this variant. This report underscores the high prevalence of the D91A variant in Europe, despite the presence of a North-South gradient in its frequency, and confirms that this variant can be associated with dominant cases in Mediterranean countries.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farrugia Wismayer</LastName><ForeName>Maia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrugia Wismayer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pace</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9488-1077</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Gozo General Hospital, Victoria, Gozo, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassallo</LastName><ForeName>Neville</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cauchi</LastName><ForeName>Ruben J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6150-1608</Identifier><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta. ruben.cauchi@um.edu.mt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. ruben.cauchi@um.edu.mt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Hum Genet</MedlineTA><NlmUniqueID>9302235</NlmUniqueID><ISSNLinking>1018-4813</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34616013</ArticleId><ArticleId IdType="pmc">PMC9259738</ArticleId><ArticleId IdType="doi">10.1038/s41431-021-00975-x</ArticleId><ArticleId IdType="pii">10.1038/s41431-021-00975-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;98. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;9. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet. 1995;10:61&#x2013;6. doi: 10.1038/ng0595-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Aguirre T, Van den Bosch L, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology. 1996;47:1336&#x2013;9. doi: 10.1212/WNL.47.5.1336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.5.1336</ArticleId><ArticleId IdType="pubmed">8909456</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini S, Giannini F, Greco G, Bibbo G, Ferrera L, Marini V, et al. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J Neurol. 2005;252:782&#x2013;8. doi: 10.1007/s00415-005-0742-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0742-y</ArticleId><ArticleId IdType="pubmed">15789135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro C, Sprovieri T, Morello G, Perrone B, Spampinato AG, Simone IL, et al. Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: a two-decade analysis. Neurobiol Aging. 2021;99:99 e7&#x2013;e14. doi: 10.1016/j.neurobiolaging.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.017</ArticleId><ArticleId IdType="pubmed">32951934</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet. 1998;7:2045&#x2013;50. doi: 10.1093/hmg/7.13.2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/7.13.2045</ArticleId><ArticleId IdType="pubmed">9817920</ArticleId></ArticleIdList></Reference><Reference><Citation>Parton MJ, Broom W, Andersen PM, Al-Chalabi A, Nigel Leigh P, Powell JF, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat. 2002;20:473. doi: 10.1002/humu.9081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.9081</ArticleId><ArticleId IdType="pubmed">12442272</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keranen ML, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 1996;119:1153&#x2013;72. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1-2 trial of antisense oligonucleotide Tofersen for SOD1 ALS. N Engl J Med. 2020;383:109&#x2013;19. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar C. A concise history of Malta. Valletta: Mireva Publications; 2000.</Citation></Reference><Reference><Citation>Cauchi MN. A picture of Gozo: studies on ethnographic, educational and health aspects of life in Gozo. Malta: Gozo Press; 1998.</Citation></Reference><Reference><Citation>Borg R, Farrugia Wismayer M, Bonavia K, Farrugia Wismayer A, Vella M, van Vugt J, et al. Genetic analysis of ALS cases in the isolated island population of Malta. Eur J Hum Genet. 2021;29:604&#x2013;14. doi: 10.1038/s41431-020-00767-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00767-9</ArticleId><ArticleId IdType="pmc">PMC8115635</ArticleId><ArticleId IdType="pubmed">33414559</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrugia Wismayer M, Borg R, Farrugia Wismayer A, Bonavia K, Vella M, Pace A, et al. Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta. Amyotroph Lateral Scler Frontotemporal Degener. 2021:1&#x2013;7. 10.1080/21678421.2021.1905847.</Citation><ArticleIdList><ArticleId IdType="pubmed">33821701</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini F, Battistini S, Mancuso M, Greco G, Ricci C, Volpi N, et al. D90A-SOD1 mutation in ALS: the first report of heterozygous Italian patients and unusual findings. Amyotroph Lateral Scler. 2010;11:216&#x2013;9. doi: 10.3109/17482960902721642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902721642</ArticleId><ArticleId IdType="pubmed">20184519</ArticleId></ArticleIdList></Reference><Reference><Citation>Origone P, Caponnetto C, Mascolo M, Mandich P. Heterozygous D90A-SOD1 mutation in an Italian ALS patient with atypical presentation. Amyotroph Lateral Scler. 2009;10:492. doi: 10.3109/17482960903055966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903055966</ArticleId><ArticleId IdType="pubmed">19922148</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>